1. Arruda, JE, McInnis, MC, Steele, J. The flash visual evoked potential-P2 and the detection of amnestic mild cognitive impairment: a review of empirical literature. Int J Psychophysiol. 2020;155:162-167. doi:10.1016/j.ijpsycho.2020.05.012
Google Scholar | Crossref | Medline2. Coburn, KL, Arruda, JE, Estes, KM, Amoss, RT. Diagnostic utility of visual evoked potential changes in Alzheimer's Disease. J Neuropsychiatry Clin Neurosci. 2003;15(2):175-179. doi:10.1176/jnp.15.2.175
Google Scholar | Crossref | Medline3. Bajalan, AA, Wright, CE, van der Vliet, VJ. Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's Disease. Journal of Neurology, Neurosurgery & Psychiatry. 1986;49(2):175-182. doi:10.1136/jnnp.49.2.175
Google Scholar | Crossref | Medline4. Case, JL, Arruda, JE, VanWormer, LA. Modeling cyclic variations in sustained human performance as measured by reaction time and the flash visual evoked potential-P2. Int J Psychophysiol. 2016;101:43-49. doi:10.1016/j.ijpsycho.2016.01.006
Google Scholar | Crossref | Medline5. Ciuffini, R . Visual evoked potentials in Alzheimer’s disease: electrophysiological study of the visual pathways and neuropsychological correlates. Journal of Alzheimer’s Disease & Parkinsonism. 2014;04(05): 1–4. doi:10.4172/2161-0460.1000158
Google Scholar | Crossref6. Harding, GFA, Daniels, R, Panchal, S, Drasdo, N, Anderson, SJ. Visual evoked potentials to flash and pattern reversal stimulation after administration of systemic or topical scopolamine. Doc Ophthalmol. 1994;86(3):311-323. doi:10.1007/bf01203554
Google Scholar | Crossref | Medline7. Bloudek, LM, Spackman, DE, Blankenburg, M, Sullivan, SD. Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer’s disease. Journal of Alzheimer’s Disease. 2011;26(4):627-645. doi:10.3233/jad-2011-110458
Google Scholar | Crossref | Medline | ISI8. Frisoni, GB, Boccardi, M, Barkhof, F, et al. Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers. The Lancet Neurology. 2017;16(8):661-676.
Google Scholar | Crossref | Medline9. Olsson, B, Lautner, R, Andreasson, U, et al. CSF And blood biomarkers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis. The Lancet Neurology. 2016;15(7):673-684. doi:10.1016/s1474-4422(16)00070-3
Google Scholar | Crossref | Medline10. Scarmeas, N, Habeck, C, Anderson, KE, et al. Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the ε4 allele). American Journal of Geriatric Psychiatry. 2004;12(6):596-605. doi:10.1097/00019442-200411000-00005
Google Scholar | Crossref | Medline11. Isaac, M, Vamvakas, S, Isaac, M. Diagnostic biomarkers for Alzheimer’s disease: a regulatory view. The Lancet Neurology. 2017;16(8):580-581. doi:10.1016/s1474-4422(17)30223-5
Google Scholar | Crossref | Medline12. Cacioppo, JT, Berntson, GG. Social neuroscience. In: Gazzaniga, MS , ed. The Cognitive Neurosciences. Mit Press; 2004:977-983.
Google Scholar13. Herholz, K, Weisenbach, S, Zündorf, G, et al. In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease. NeuroImage. 2004;21(1):136-143. doi:10.1016/j.neuroimage.2003.09.042
Google Scholar | Crossref | Medline14. Iyo, M, Namba, H, Fukushi, K, et al. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer’s disease. The Lancet. 1997;349(9068):1805-1809. doi:10.1016/s0140-6736(96)09124
Google Scholar | Crossref | Medline15. Kar, S, Slowikowski, SPM, Westaway, D, Mount, HTJ. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer’s disease. Journal of Psychiatry and Neuroscience. 2004;6:427-441.
Google Scholar16. Ladner, CJ, Lee, JM. Pharmacological drug treatment of Alzheimer disease: the cholinergic hypothesis revisited. J Neuropathol Exp Neurol. 1998;57(8):719-731. doi:10.1097/00005072-199808000-00001
Google Scholar | Crossref | Medline17. Niikura, T, Tajima, H, Kita, Y. Neuronal cell death in alzheimers disease and a neuroprotective factor, humanin. Curr Neuropharmacol. 2006;4(2):139-147. doi:10.2174/157015906776359577
Google Scholar | Crossref | Medline18. Coburn, KL, Ashford, JW, Moreno, MA. Visual evoked potentials in dementia: selective delay of flash P2 in probable Alzheimer’s disease. J Neuropsychiatry Clin Neurosci. 1991;3(4):431-435. doi:10.1176/jnp.3.4.431
Google Scholar | Crossref | Medline19. Fix, ST, Arruda, JE, Andrasik, F, Beach, J, Groom, K. Using visual evoked potentials for the early detection of amnestic mild cognitive impairment: a pilot investigation. Int J Geriatr Psychiatry. 2014;30(1):72-79. doi:10.1002/gps.4117
Google Scholar | Crossref | Medline20. Moore, NC, Vogel, RL, Tucker, KA, Khairy, NM, Coburn, KL. P2 flash visual evoked response delay May Be a marker of cognitive dysfunction in healthy elderly volunteers. Int Psychogeriatr. 1996;8(4):549-559. doi:10.1017/s1041610296002876
Google Scholar | Crossref | Medline21. Orwin, A, Wright, CE, Harding, GF, Rowan, DC, Rolfe, EB. Serial visual evoked potential recordings in Alzheimer’s disease. Br Med J. 1986;293(6538):9-10. doi:10.1136/bmj.293.6538.9
Google Scholar | Crossref | Medline22. Parks, RW, Zec, RF, Kuhn, M, et al. Electrocortical mapping, MRI, and neuropsychological measures: evidence of Alzheimer’s disease in the presence of vascular lesions. Arch Clin Neuropsychol. 1991;6(4):393-408. doi:10.1093/arclin/6.4.393
Google Scholar | Crossref | Medline23. Ponomareva, NV, Fokin, VF, Selesneva, ND, Voskresenskaia, NI. Possible neurophysiological markers of genetic predisposition to Alzheimer’s disease. Dement Geriatr Cogn Disord. 1998;9(5):267-273. doi:10.1159/000017071
Google Scholar | Crossref | Medline24. Kalaria, R . Similarities between Alzheimer’s disease and vascular dementia. J Neurol Sci. 2002;203-204:29-34.
Google Scholar | Crossref | Medline | ISI25. Odom, JV, Bach, M, Brigell, M, et al. ISCEV Standard for clinical visual evoked potentials: (2016 update). Documenta Ophthalmologica Advances in Ophthalmology. 2016;133(1):1-9. doi:10.1007/s10633-016-9553-y
Google Scholar | Crossref | Medline26. Odom, JV, Bach, M, Brigell, M, et al. ISCEV Standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol. 2010;120(1):111-119. doi:10.1007/s10633-009-9195-4
Google Scholar | Crossref | Medline | ISI27. Arruda, JE, Steele, J, McInnis, MC, Rainey, VR, Wade, A. The effect of wavelength on the variability of the flash visual evoked potential P2: a potential biomarker for mild cognitive impairment and Alzheimer’s dementia. Int J Psychophysiol. 2021;164:23-29. doi:10.1016/j.ijpsycho.2021.02.011
Google Scholar | Crossref | Medline28. McKhann, G, Drachman, D, Folstein, M, Katzman, R, Price, D, Stadlan, EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group* under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology. 1984;34(7):939-939. doi:10.1212/wnl.34.7.939
Google Scholar | Crossref | Medline | ISI29. Moore, NC, Tucker, KA, Jann, MW, Hostetler, RM, Coburn, KL. Flash P2 delay in primary degenerative dementia of the Alzheimer type. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 1995;19(3):403-410. doi:10.1016/0278-5846(95)00021-m
Google Scholar | Crossref | Medline30. Hebert, LE, Weuve, J, Scherr, PA, Evans, DA. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology. 2013;80(19):1778-1783. doi:10.1212/wnl.0b013e31828726f5
Google Scholar | Crossref | Medline | ISI31. Feldman, H, Levy, AR, Hsiung, G-Y, et al. A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology. 2003;22(5):265-274. doi:10.1159/000071189
Google Scholar | Crossref | Medline | ISI32. Jacova, C, Kertesz, A, Blair, M, Fisk, JD, Feldman, HH. Neuropsychological testing and assessment for dementia. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. 2007;3(4):299-317.
Google Scholar | Crossref | Medline | ISI33. Lamb, TD, Gegenfurtner, K, Sharpe, LT. Photopigments and the biophysics of transduction incone photoreceptors. Color Vision: From Genes to Perception. 1999:89-101.
Google Scholar34. Smith, NP, Lamb, TD. The a-wave of the human electroretinogram recorded with a minimally invasive technique. Vision Res. 1997;37(21):2943-2952. doi:10.1016/s0042-6989(97)00094-1
Google Scholar | Crossref | Medline35. Salesse, C . Physiology of the visual retinal signal: from phototransduction to the visual cycle. Journal Francais D’Ophtalmologie. 2017;40(3):239-250.
Google Scholar | Crossref | Medline36. Perry, RJ, McNaughton, PA. Response properties of cones from the retina of the tiger salamander. J Physiol. 1991;433(1):561-587. doi:10.1113/jphysiol.1991.sp018444
Google Scholar | Crossref | Medline37. Chatterjee, S, Callaway, EM. S cone contributions to the magnocellular visual pathway in macaque monkey. Neuron. 2002;35(6):1135-1146. doi:10.1016/s0896-6273(02)00874-7
Google Scholar | Crossref | Medline38. Roorda, A, Williams, DR. The arrangement of the three cone classes in the living human eye. Nature. 1999;397(6719):520-522. doi:10.1038/17383
Google Scholar | Crossref | Medline39. Roorda, A, Metha, AB, Lennie, P, Williams, DR. Packing arrangement of the three cone classes in primate retina. Vision Res. 2001;41(10-11):1291-1306. doi:10.1016/s0042-6989(01)00043-8
Google Scholar | Crossref | Medline40. Sharpe, LT, Stockman, A, Jägle, H, Nathans, J. Opsin genes, cone photopigments, color vision, and color blindness. Color Vision: From Genes to Perception. 1999:3-51.
Google Scholar41. Subramanian, SK, Gaur, GS, Narayan, SK. Effect of color of flash stimulus on variability of flash visual evoked potential latencies. Indian J Physiol Pharmacol. 2012;56:322-329.
Google Scholar | Medline